Denmark· DK-28107133224
Ogsiveo
A other antineoplastic agents product containing nirogacestatdihydrobromid, registered in Denmark by Merck Europe B.V.. The same ATC class is registered in 5 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Nirogacestatdihydrobromid is registered in 5 of 19 countries.
Countries holding a registration under ATC L01XX (other antineoplastic agents), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 3 of them publish a price we can compare per daily dose
Nirogacestatdihydrobromid · ATC L01XX
5 / 19 countries
- Denmark
- Finlandprice
- Ireland
- Polandprice
- United Statesprice
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Nirogacestatdihydrobromid
- Manufacturer
- Merck Europe B.V.
- Country
- Denmark (DK)
- ATC code
- L01XX
- ATC class
- Other antineoplastic agents
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28107133224
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under L01XX
Other antineoplastic agents, as other registers publish it.
- United StatesGUNA-ALLERGY TGuna spa
- United StatesHeadacheNewton Laboratories, Inc.
- United StatesHeadacheNewton Laboratories, Inc.
- United StatesInsomniaBioActive Nutritional, Inc.
- IrelandOdomzo 200 mg hard capsulesSun Pharmaceutical Industries Europe B.V.
- PolandOgsiveoSpringWorks Therapeutics Ireland Limited
- PolandOgsiveoSpringWorks Therapeutics Ireland Limited
- PolandOgsiveoSpringWorks Therapeutics Ireland Limited
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f011ebb6-0331-4672-82e2-51b9ebff0127 GET /v1/drugs/f011ebb6-0331-4672-82e2-51b9ebff0127?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "filmovertrukne tabletter",
"source": "dkma",
"strength": "50 mg",
"auth_role": "MOD",
"dk_drugid": "28107133224",
"substance": "Nirogacestatdihydrobromid",
"auth_procedure": "Central",
"in_medicinpriser": false,
"registration_date_serial": "45883"
}See everything about nirogacestatdihydrobromid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.